Sign In
to Vote &
Create Storyboards.
 
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma which may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. The study was published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "About 35 percent of melanomas are considered 'pan-negative,' which means they are devoid of any previously known driver mutations in the genes BRAF, NRAS, K...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard